Wednesday 24 May 2017

Thermo Fisher to buy Patheon for $5.2bn

Thermo Fisher Scientific said on Monday it would buy Dutch-based Patheon, a global leader in pharmaceutical and biopharma sectors, for $5.2 billion. Thermo Fisher will commence a tender offer to acquire all of the issued and outstanding shares of Patheon for $35.00 per share in c

 < 1 2

calendarCalendar of Events